GENE ONLINE|News &
Opinion
Blog

China
I-Mab Inks $315 Million Pact with Jumpcan to Market Human Growth Hormone in China
2021-11-11
Zai Lab Buys Rights to Three Assets, Including Its First Neuroscience Drug
2021-11-10
Chinese Vaccine Maker Raises $240 Million in Hong Kong Debut
2021-11-08
WuXi Biologics Launch Its Largest GMP Drug Facility and First Automated Vial Packaging Line
2021-11-03
Shanghai Startup Lands $325 Million Nasdaq IPO to Advance Phase 3 Assets
2021-11-02
Angel Pharma Pushes First-In-Class ITK Inhibitor into Trial in China
2021-10-27
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
Diabetes Care Device Maker Debuts On Hong Kong Exchange
2021-10-20
WuXi ATU Launches Fourth Manufacturing Site for Gene and Cell Therapy CTDMO Service
2021-10-19
Is the Race On for RNAi? A Chinese Pharma’s $450M Deal May Just Be the Start
2021-10-13
China’s Metabolic Drugmaker Scores $70M Series C to Accelerate Drug Trials
2021-10-13
BeiGene Gets Its First Regulatory Nod in Australia for Rare Lymphoma
2021-10-08
2021 CSCO Highlights: JW Therapeutics, Innovent, Ambrx, HUTCHMED Release Latest Data on Cancer Drugs
2021-10-07
Zai Lab, Turning Point’s Solid Tumor Treatment Repotrectinib Gets FDA Breakthrough Therapy Designation
2021-10-06
I-Mab Gets China NMPA Greenlight to Trial Combination Therapy in Solid Tumors
2021-09-30
1 3 4 5 6 7 8
LATEST
Innovative Cellular Mapping of BRCA-Related Breast Cancer Findings Reveals Novel Therapeutic Targets
2024-03-29
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top